Disease Prevention and Control / Noncommunicable Diseases / Diabetes

CAMDI V Workshop: Diabetes Surveillance and Control in Central America

(Montelimar, Nicaragua, 29–30 April 2004)

CAMDI

Final Report
(in Spanish, 63 pp, PDF, 1377 KB; links in Table of Contents to chapters, titles translated below)

- Abstract  | - Introduction
- Objectives   |   - Welcome
- Inauguration   |   - Metodology &Status of Initiative
- Proposal for Survey Data Analysis
- Working-Group Reports: El Salvador, Honduras, Nicaragua, Guatemala
- Status & Perspectives for Work in Belize, Costa Rica & Panama
- Policies for Utilizing Survey Data & Publishing Results
- Evaluating Prevention & Control Resources: Preliminary Results of Salvadoran Evaluation
- Phase 2 Proposals: Regional Perspective
- Conclusions of Discussion Group on Priorities and Steps to Follow for Phase 2
- Annexes:
1: Country Members of CAMDI Committees
2: Questionnaire for NCD Surveillance
3: Agenda
4: List of Participants

About CAMDI
Other CAMDI Workshops:
IV   |   III   |   II   |   I

About DOTA

Other diabetes projects:
- VIDA Project

PAHO Diabetes Page
Objectives Abstract
General Specific
  1. Review the progress and results of the activities related to the multinational survey of diabetes, obesity, hypertension, and factors of risk for noncommunicable diseases (NCDs).
  2. Establish policies and procedures to follow for utilizing and publishing the survey data.
  3. Contribute to designing the plan of action and strategies to be utilized for Phase 2 implementation.
  1. Present the activities carried out and in process in each country, as well as any preliminary results.
  2. Prepare the data-analysis plan.
  3. Establish policies for data utilization of data and publication of survey results.
  4. Prepare proposals and coordinate strategies for Phase 2 implementation.
  5. Design strategies aimed at involving and integrating other countries of the subregion (Belize, Costa Rica, and Panama).

Abstract

The Vth Workshop of the Central American Diabetes Initiative Diabetes (CAMDI) was held from 29 to 30 April 2004 at the Hotel Montelimar Barceló in Montelimar, Nicaragua. Attending the workshop were 22 representatives, from Belize, Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua, and Panama, as well as officials from the Control Centers for Disease Control and Prevention of the United States (CDC) and PAHO Headquarters in Washington, DC. The workshop included a status report on the multinational diabetes survey being developed as a Phase 1 CAMDI activity supported by CDC.

Guatemala already concluded Phase 1 and results indicated a diabetes prevalence of 8.4%. The results were presented officially to the Ministry of the Health, with the presence of other institutions and organizations. A ministerial committee has been formed to prepare a National Plan for Noncommunicable Disease Prevention and Control.

Nicaragua finished both the survey and initial data entry; it is now involved in the data-cleaning and validation phase. Honduras is finishing the survey and will now begin data input, recapture, and analysis. El Salvador recently began the survey and, according to their timetable, should finish it in mid-August.

An evaluation of resources for diabetes control was conducted in El Salvador, with a grant from the pharmaceutical company Novo Nordisk. Additional evaluations are now being completed in the other four countries participating in the initiative. Preliminary results were presented during the workshop.

Other workshop activities included defining policies for data utilization and publication of survey results. A committee structure was established to carry out study objectives. This includes a scientific committee, a management and analysis committee, and primary- and secondary-prevention committees. The countries should select one or two representatives to participate in each of them.

Taking into account the priorities identified by the countries during the previous workshop, a proposal was submitted for a plan of regional action plan to develop Phase 2 of the initiative. This report submits the proposals for CAMDI activities in the areas of risk-factor monitoring, diabetes education, assessing the quality of care, and preparing and implementing care and service-improvement guides.